Drug intelligence / Profile preview

Zoalene

Development stage
Unknown
Lead developer
Zoetis
Modality
Small Molecules
Administration
Oral
01

Overview

Zoalene, also known as Dinitolmide, is a synthetic, non-ionophorous coccidiostat primarily used as a fodder additive for poultry, including chickens and turkeys, and domestic rabbits to prevent and control coccidiosis infections. It is a broad-spectrum anticoccidial drug effective against various Eimeria species. While its precise molecular mechanism is not fully elucidated, it is hypothesized to interfere with critical metabolic pathways within the Eimeria parasite. Zoalene specifically targets the early stages of the Eimeria life cycle, particularly the first-generation schizonts, disrupting their metabolic processes and inhibiting their growth and replication. It also has an inhibitory effect on the sporulation process of oocysts. A notable characteristic of Zoalene is its ability to permit a degree of parasite cycling, which facilitates the development of natural immunity in the host birds.

Brand names
Coccidine ACoccidotZoamixZoaShieldZoacox
Other names
Dinitolmide3,5-dinitro-o-toluamide2-methyl-3,5-dinitrobenzamideDinitro-o-toluamideDinitroD.O.T.MethyldinitrobenzamideDinitolmidaDinitolmidumSalcostatZoaleleo-Toluamide, 3,5-dinitro-NSC-758213NSC758213NSC 758213

Beyond the preview

Go deeper on Zoalene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zoalene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call